170 related articles for article (PubMed ID: 10222055)
1. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection.
Kamperschroer C; Quinn DG
Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055
[TBL] [Abstract][Full Text] [Related]
2. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
3. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus.
Varga SM; Welsh RM
J Immunol; 1998 Oct; 161(7):3215-8. PubMed ID: 9759834
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
5. Stability of virus-specific CD4+ T cell frequencies from acute infection into long term memory.
Varga SM; Welsh RM
J Immunol; 1998 Jul; 161(1):367-74. PubMed ID: 9647245
[TBL] [Abstract][Full Text] [Related]
6. Effects of IL-12 on the response and susceptibility to experimental viral infections.
Orange JS; Wolf SF; Biron CA
J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
[TBL] [Abstract][Full Text] [Related]
7. Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection.
Oxenius A; Bachmann MF; Mathis D; Benoist C; Zinkernagel RM; Hengartner H
J Immunol; 1997 Jun; 158(12):5717-26. PubMed ID: 9190921
[TBL] [Abstract][Full Text] [Related]
8. Uneven distribution of MHC class II epitopes within the influenza virus.
Crowe SR; Miller SC; Brown DM; Adams PS; Dutton RW; Harmsen AG; Lund FE; Randall TD; Swain SL; Woodland DL
Vaccine; 2006 Jan; 24(4):457-67. PubMed ID: 16140434
[TBL] [Abstract][Full Text] [Related]
9. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
10. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
Zimmermann C; Pircher H
J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
[TBL] [Abstract][Full Text] [Related]
13. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
Ohashi PS; Oehen S; Aichele P; Pircher H; Odermatt B; Herrera P; Higuchi Y; Buerki K; Hengartner H; Zinkernagel RM
J Immunol; 1993 Jun; 150(11):5185-94. PubMed ID: 8496610
[TBL] [Abstract][Full Text] [Related]
14. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
[TBL] [Abstract][Full Text] [Related]
15. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice.
Thomsen AR; Johansen J; Marker O; Christensen JP
J Immunol; 1996 Oct; 157(7):3074-80. PubMed ID: 8816417
[TBL] [Abstract][Full Text] [Related]
16. Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen.
Jellison ER; Guay HM; Szomolanyi-Tsuda E; Welsh RM
Eur J Immunol; 2007 Jan; 37(1):119-28. PubMed ID: 17163452
[TBL] [Abstract][Full Text] [Related]
17. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection.
Selin LK; Welsh RM
J Immunol; 1997 Jun; 158(11):5366-73. PubMed ID: 9164957
[TBL] [Abstract][Full Text] [Related]
18. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM
Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834
[TBL] [Abstract][Full Text] [Related]
19. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.
Zajac AJ; Vance RE; Held W; Sourdive DJ; Altman JD; Raulet DH; Ahmed R
J Immunol; 1999 Nov; 163(10):5526-34. PubMed ID: 10553080
[TBL] [Abstract][Full Text] [Related]
20. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
Zeller JC; Nguyen N; Southern PJ
Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
